Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

609
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
609
Cancer Prevention02:59

Cancer Prevention

3.0K
3.0K
Radiological Investigation II: MRI and Ventilation Perfusion Scan01:30

Radiological Investigation II: MRI and Ventilation Perfusion Scan

808
Description
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
808

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Sarcomas-Red flags for radiology].

Radiologie (Heidelberg, Germany)·2026
Same author

[Prof. Dr. Gerhard van Kaick on his 90<sup>th</sup> birthday].

Radiologie (Heidelberg, Germany)·2025
Same author

[Everything flows-πάντα ῥεῖ].

Radiologie (Heidelberg, Germany)·2024
Same author

[The old auntie].

Radiologie (Heidelberg, Germany)·2023
Same author

[The big mystery-a second look].

Radiologie (Heidelberg, Germany)·2023
Same author

[Interdisciplinary discussions, consultative findings and communication of results].

Radiologie (Heidelberg, Germany)·2023
Same journal

Der Radiologe·2024
Same journal

Der Radiologe·2024
Same journal

Der Radiologe·2024
Same journal

Der Radiologe·2024
Same journal

Der Radiologe·2022
Same journal

Der Radiologe·2022
See all related articles

Related Experiment Video

Updated: Mar 16, 2026

Author Spotlight: Demonstrating Systematic Endobronchial Ultrasound to New Endoscopists
05:22

Author Spotlight: Demonstrating Systematic Endobronchial Ultrasound to New Endoscopists

Published on: August 11, 2023

3.0K

[Prerequisites for a successful lung cancer screening program].

N Becker1, S Delorme2

  • 1Abteilung Krebsepidemiologie, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 581, 69120, Heidelberg, Deutschland. n.becker@dkfz.de.

Der Radiologe
|August 10, 2016
PubMed
Summary
This summary is machine-generated.

Low-dose computed tomography (CT) screening shows potential for reducing lung cancer mortality. However, the benefit-to-harm balance is narrow, requiring careful optimization of screening programs for high-risk individuals.

Keywords:
Early detectionLUSI studyLung cancer mortalityNLST studyRandomized trial

Related Experiment Videos

Last Updated: Mar 16, 2026

Author Spotlight: Demonstrating Systematic Endobronchial Ultrasound to New Endoscopists
05:22

Author Spotlight: Demonstrating Systematic Endobronchial Ultrasound to New Endoscopists

Published on: August 11, 2023

3.0K

Area of Science:

  • Pulmonology
  • Radiology
  • Oncology

Background:

  • The National Lung Screening Trial (NLST) demonstrated reduced lung cancer mortality using low-dose computed tomography (CT).
  • European trials have yielded mixed preliminary results regarding lung cancer mortality reduction.
  • Upcoming evaluations of the NELSON trial and other European studies are anticipated.

Purpose of the Study:

  • To evaluate the effectiveness of low-dose computed tomography (CT) screening in reducing lung cancer mortality.
  • To analyze the benefit-to-harm balance of lung cancer screening programs.
  • To identify critical factors for optimizing lung cancer screening programs.

Main Methods:

  • Analysis of data from the National Lung Screening Trial (NLST).
  • Review of preliminary results from European lung cancer screening trials.
  • Anticipation of final results from the NELSON trial and other European studies.

Main Results:

  • The NLST confirmed a reduction in lung cancer mortality with low-dose multislice computed tomography (MSCT).
  • Preliminary European trial evaluations did not consistently confirm this reduction.
  • Results suggest a narrow margin for a positive benefit-to-harm balance in lung cancer screening.

Conclusions:

  • Optimizing the target population (high-risk individuals) is crucial for lung cancer screening.
  • High sensitivity, specificity, quality treatment, and program control are essential for effective screening.
  • Not all healthcare systems possess the necessary infrastructure to meet these prerequisites for lung cancer screening.